Subsequently, the therapeutic effects of EA at acupoints Baihui (GV20), Guanyuan (CV4), and Zusanli (ST36), as well as sunitinib, a PDGFRβ‐specific inhibitor, on AD‐like phenotypes in APP/PS1 mice were investigated. Here, APP is linked to Alzheimer disease.